Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Filings indexed 881 across all filing types
Latest filing 2011-04-10 Regulatory Filings
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Phosphagenics to Launch New Cellulite Cosmetics 2 pages 82.6KB
Regulatory Filings Classification · 95% confidence The document is a company announcement about the launch of a new cosmetic product and the results of related trials. It contains promotional and product information, trial results, and company background, but it does not include any financial statements, regulatory filings, or detailed financial data. It is not an earnings release, annual report, or any formal regulatory filing. It is a press release or announcement about a product launch and trial results, which fits best under the category of Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2011-04-10 English
Phosphagenics New ELIXIA Skincare Products Launch 2 pages 76.5KB
Regulatory Filings Classification · 95% confidence The document is a company announcement about the launch of new skincare products on a shopping TV channel. It includes promotional information, CEO statements, and background about the company and its technology. There is no financial data, regulatory filing references, voting results, or management changes. The document is a general corporate announcement about product launch and marketing activities, not a financial report, regulatory filing, or shareholder communication. Therefore, it best fits the category of a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2011-04-06 English
Phosphagenics Collaboration To Develop Anti-acne Drug 2 pages 73.6KB
Regulatory Filings Classification · 95% confidence The document is a company announcement about a collaboration agreement to develop an anti-acne drug. It discusses the terms of the agreement, the technology involved, and future plans but does not contain any financial statements, detailed financial performance data, or regulatory filing references. The document length is short (2902 characters) and reads like a press release or announcement rather than a formal report. There is no indication that this is an Annual Report, Earnings Release, or any other detailed financial or regulatory filing. It is not a report publication announcement either, as it contains substantive information about a business collaboration. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous company announcements that do not fit other categories.
2011-04-03 English
December 2010 Full Year Statutory Accounts 71 pages 742.9KB
Annual Report Classification · 100% confidence The document is titled 'Annual Financial Report for the year ended 31 December 2010' and contains detailed sections typical of a full annual report, including Directors' Report, Auditors Independence Declaration, Corporate Governance Statement, Consolidated Financial Statements, Notes to the Financial Statements, Directors' Declaration, and Independent Auditor's Report. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement. The content includes comprehensive financial data, management discussion, and governance information for the full fiscal year ending December 31, 2010. Therefore, this document fits the definition of an Annual Report (10-K equivalent). FY 2010
2011-03-29 English
Section 708A Cleansing Notice 1 page 43.1KB
Share Issue/Capital Change Classification · 95% confidence The document is a notice under Section 708A of the Corporations Act 2001 (Cth) regarding the issuance of new shares by the company through a placement to institutional and professional investors. It provides legal compliance statements related to the share issuance and disclosure obligations. The document is short (1506 characters) and is an announcement of a capital raising event rather than a full financial report or detailed financing update. This fits the category of a Share Issue/Capital Change announcement, as it relates to new share issuance and compliance notices under the Corporations Act.
2011-03-20 English
Appendix 3B Notice - Equity Raising 8 pages 185.3KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B form, which is a standard ASX (Australian Securities Exchange) form used to announce new issues of securities, including details such as number of shares issued, issue price, and purpose of the issue. It includes detailed information about the placement of new ordinary shares, reconciliation of unquoted options, and the application for quotation of these securities on the ASX. The document is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital raising event and securities issuance. This fits the definition of a Share Issue/Capital Change announcement (SHA). The document length and content confirm it is the announcement itself, not a brief notice or a report publication announcement.
2011-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.